Informatie:
Fout:
ID
34343
Beschrijving
Aspirin in Reduction of Tension II Study; ODM derived from: https://clinicaltrials.gov/show/NCT01379079
Link
https://clinicaltrials.gov/show/NCT01379079
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
GSK group of companies
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hypertension NCT01379079
Eligibility Hypertension NCT01379079
- StudyEvent: Eligibility
Similar models
Eligibility Hypertension NCT01379079
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
use of low-dose aspirin (acetylsalicylic acid or carbasalate calcium 80- 100mg [brand names: acetylsalicylic acid cardio, aspirin protect, ascal cardio, carbasalate calcium cardio]) for secondary prevention of cardiovascular events
boolean
ID.2
Item
stable blood pressure (with or without therapy) between 120/70 and 159/99
boolean
ID.3
Item
age 18-80 year
boolean
ID.4
Item
capacity to give informed consent (ic)
boolean
ID.5
Item
blood pressure lower than 120/70 or higher than 159/99
boolean
ID.6
Item
change in blood pressure lowering medication within the last three months
boolean
ID.7
Item
regular use of non-steroidal anti-inflammatory drugs (nsaid's)
boolean
ID.8
Item
shift workers
boolean
ID.9
Item
evidence of secondary arterial hypertension
boolean
ID.10
Item
pregnancy
boolean